Eat Well Heart Failure
Eat Well Produce Prescription for Duke Health Patients With Congestive Heart Failure
1 other identifier
interventional
900
1 country
1
Brief Summary
The purpose of this parallel pragmatic randomized controlled trial (RCT) is to evaluate the impact of Eat Well (an evidence-based 'Food is Medicine' produce prescription program) with varying levels of behavioral support on health outcomes and care utilization patterns of Duke Health patients diagnosed with congestive heart failure (CHF). Objectives of this three arm trial include testing the effectiveness of Eat Well alone with minimal behavioral support and Eat Well with intensified behavioral support based on an evidence based approach to improve CHF patients' health outcomes, estimating health care cost savings between the intervention and control arms, and identifying barriers, facilitators, and potential strategies to enhance Eat Well effectiveness and implementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedStudy Start
First participant enrolled
October 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
November 12, 2025
November 1, 2025
1.1 years
July 28, 2025
November 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite of incidence rates of ED visits, hospitalizations, and all-cause mortality at 12 months
The primary outcome of interest will be a composite endpoint of: ED visits, hospitalizations, and all-cause mortality at 12 months.
12 months
Secondary Outcomes (10)
All cause hospitalizations
12 months
All cause ED visits
12 months
Outpatient utilization
12 months
Change in Blood pressure
12 months
Change in Body Mass Index
12 months
- +5 more secondary outcomes
Study Arms (3)
Usual Care
NO INTERVENTIONPatients will continue to receive their usual care as well as educational materials
Prescription Produce program with low behavioral support
ACTIVE COMPARATORPatients will receive the Eat Well Prescription Produce benefit card ($100/month for 12 months) with low behavioral support provided by Reinvestment Partners
Prescription Produce program with high behavioral support
ACTIVE COMPARATORPatients will receive the Eat Well Prescription produce benefit card ($100/month for 12 months) with high behavioral support provided by Reinvestment Partners and ZealCare
Interventions
Behavioral support will be offed by ZealCare, an evidence-based, virtual coaching behavioral support program for patients with chronic conditions.
Eat Well is a prescription produce program that provides a reloadable, restricted use debit card to participants to purchase fresh, frozen, or canned fruits, vegetables, and legumes at grocery stores.
Eligibility Criteria
You may qualify if:
- Age 18 or older
- Diagnosis of CHF regardless of ejection fraction AND
- Hospitalization or ED visit within the past 12 months AND
- At risk of food insecurity as defined by one of the following:
- screened positive for financial instability (medium risk and up) or food insecurity in the past 12 months minimum OR a Medicaid or dual eligible enrollee
- English as preferred language
- Valid email address (for virtual health coaching intervention)
- NC mailing address
You may not qualify if:
- History of dialysis or end stage renal disease OR
- History of LVAD or heart transplant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Reinvestment Partnerscollaborator
- ZealCarecollaborator
Study Sites (1)
Duke Health
Durham, North Carolina, 27701, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Connor Drake, PhD
Duke Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2025
First Posted
August 3, 2025
Study Start
October 22, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
November 12, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share